Grace Therapeutics, Inc. (GRCE) — Working Capital to Net Assets Ratio
Grace Therapeutics, Inc. (GRCE) has a Working Capital to Net Assets ratio of 27.6% as of December 2025. Working capital of $17.93 Million (current assets of $19.21 Million minus current liabilities of $1.28 Million) is measured against net assets of $64.89 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Grace Therapeutics, Inc. (GRCE) flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Grace Therapeutics, Inc. Working Capital to Net Assets (2010–2025)
This chart shows how Grace Therapeutics, Inc.'s Working Capital to Net Assets ratio has evolved across 15 annual periods from 2010 to 2025. As of December 2025, the ratio stands at 27.6%, reflecting working capital of $17.93 Million against net assets of $64.89 Million USD. See GRCE days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Grace Therapeutics, Inc. (2010–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Grace Therapeutics, Inc. from 2010 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Grace Therapeutics, Inc..
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 31.2% | $20.78 Million | $66.61 Million | $22.71 Million | $1.93 Million | ▼ -5.0 pp |
| 2024 | 36.2% | $22.33 Million | $61.74 Million | $24.01 Million | $1.68 Million | ▼ -1.9 pp |
| 2023 | 38.1% | $25.88 Million | $67.95 Million | $29.29 Million | $3.41 Million | ▼ -1.0 pp |
| 2022 | 39.0% | $42.27 Million | $108.27 Million | $45.53 Million | $3.26 Million | ▼ -70.2 pp |
| 2021 | 109.2% | $60.79 Million | $55.66 Million | $62.37 Million | $1.58 Million | ▲ +43.3 pp |
| 2020 | 65.9% | $8.56 Million | $12.99 Million | $15.96 Million | $7.39 Million | ▼ -63.6 pp |
| 2019 | 129.5% | $14.30 Million | $11.04 Million | $27.97 Million | $13.67 Million | ▲ +95.5 pp |
| 2018 | 34.0% | $2.16 Million | $6.37 Million | $7.35 Million | $5.19 Million | ▼ -3.4 pp |
| 2016 | 37.4% | $7.52 Million | $20.09 Million | $8.36 Million | $842.00K | ▼ -16.8 pp |
| 2015 | 54.2% | $14.40 Million | $26.56 Million | $15.70 Million | $1.30 Million | ▼ -19.8 pp |
| 2014 | 74.1% | $22.15 Million | $29.91 Million | $23.20 Million | $1.05 Million | ▲ +39.0 pp |
| 2013 | 35.1% | $3.33 Million | $9.50 Million | $5.72 Million | $2.39 Million | ▼ -17.4 pp |
| 2012 | 52.5% | $7.64 Million | $14.55 Million | $8.91 Million | $1.27 Million | ▲ +84.7 pp |
| 2011 | -32.2% | $-1.88 Million | $5.83 Million | $3.36 Million | $5.24 Million | ▲ +67.8 pp |
| 2010 | -100.0% | $-4.02 Million | $4.02 Million | $866.65K | $4.88 Million | — |